QDEL

QuidelOrthoA

Nasdaq / Health Care Equipment & Services

At close

2026-07-18

Current thesis

LEX, High-Sensitivity Troponin, and VITROS 450 could improve the portfolio mix and restore growth if launches gain adoption, while Immunohematology's Q1 growth provides a partial offset to respiratory weakness.

Posture

Constructive

Lead driver

Momentum

What changed

Momentum remains the lead driver in the composite, 7D delta +20.7.

What can break

Final China NHSA IVD pricing rules and implementation timing remain uncertain.

Momentum

Value

Sentiment

Setup hits (3d)

— · Net —

AI TargetsBase $20.50 · Bull $25.00 · Bear $13.50

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

As of 2026-07-18 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade A · Constructive

Confidence Medium · Net —

Target $20.50

Why

Momentum89 · Δ7d +20.7

Value54 · Δ7d +0.3

Sentiment62 · Δ7d +1.7

So what

Strength-led posture. Favor watchlist adds and disciplined entries.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Momentum · See technicals

Momentum

26% active weight

Current posture

7d trendImproving

Δ7d

+20.7

Δ21d

+57.8

Value

39% active weight

Current posture

7d trendFlat

Δ7d

+0.3

Δ21d

+0.0

Sentiment

34% active weight

Current posture

7d trendImproving

Δ7d

+1.7

Δ21d

-47.1

Why this grade

Composite grade A. Momentum 89.5 / Value 54.0 / Sentiment 62.0

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$1.19B

Beta

0.68

Shares Out

68.19M

P/E (TTM) · Derived

-1.0

P/S (TTM)

0.75

P/FCF (TTM)

106.34

Rev YoY

-10.7%

EPS YoY

+615.2%

Gross Margin

+38.0%

Op Margin

-35.3%

Net Debt

$2.66B

Current Ratio

1.43

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology